S Maragall

469 total citations
16 papers, 343 citations indexed

About

S Maragall is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, S Maragall has authored 16 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in S Maragall's work include Platelet Disorders and Treatments (7 papers), Hemophilia Treatment and Research (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). S Maragall is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Hemophilia Treatment and Research (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). S Maragall collaborates with scholars based in Spain, France and Nigeria. S Maragall's co-authors include Ginés Escolar, Joan Carles Reverter, Dolors Tàssies, A Ordinas, Antonio Ordinas, Joan Monteagudo, R. Castillo, Joan Rodés, Antoni Mas and Vicente Arroyo and has published in prestigious journals such as The Lancet, Gut and British Journal of Haematology.

In The Last Decade

S Maragall

13 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Maragall Spain 8 126 81 58 44 43 16 343
Eliane Bandinelli Brazil 11 92 0.7× 66 0.8× 36 0.6× 28 0.6× 43 1.0× 33 466
I. A. G. Reilly United Kingdom 12 177 1.4× 11 0.1× 24 0.4× 141 3.2× 24 0.6× 16 584
Nuria García‐Barberá Spain 14 85 0.7× 95 1.2× 12 0.2× 85 1.9× 14 0.3× 23 488
C Cordova Italy 12 47 0.4× 24 0.3× 147 2.5× 62 1.4× 146 3.4× 28 401
Caroline Moreau France 10 39 0.3× 156 1.9× 58 1.0× 53 1.2× 97 2.3× 37 445
J Clèdes France 14 62 0.5× 42 0.5× 18 0.3× 15 0.3× 37 0.9× 51 546
Virginia Pérez-Andreu Spain 11 140 1.1× 105 1.3× 10 0.2× 98 2.2× 10 0.2× 13 516
Sandro Parrotto Italy 6 25 0.2× 21 0.3× 30 0.5× 67 1.5× 78 1.8× 6 355
G. D. Qureshi United States 10 279 2.2× 39 0.5× 9 0.2× 154 3.5× 44 1.0× 21 737

Countries citing papers authored by S Maragall

Since Specialization
Citations

This map shows the geographic impact of S Maragall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Maragall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Maragall more than expected).

Fields of papers citing papers by S Maragall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Maragall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Maragall. The network helps show where S Maragall may publish in the future.

Co-authorship network of co-authors of S Maragall

This figure shows the co-authorship network connecting the top 25 collaborators of S Maragall. A scholar is included among the top collaborators of S Maragall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Maragall. S Maragall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Escolar, Ginés, Jordi Bozzo, & S Maragall. (2006). Argatroban: A direct thrombin inhibitor with reliable andpredictable anticoagulant actions. Drugs of today. 42(4). 223–223. 34 indexed citations
2.
Tàssies, Dolors, Joan Monteagudo, S Maragall, A Ordinas, & Joan Carles Reverter. (2005). No impact of factor IX Ala-10 mutations in acenocoumarol-treated southern Europeans. Blood Coagulation & Fibrinolysis. 16(8). 563–566. 2 indexed citations
3.
Tàssies, Dolors, et al.. (2002). Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation.. PubMed. 87(11). 1185–91. 87 indexed citations
4.
Galán, Ana M., Raúl Tonda, Carmen Altisent, et al.. (2001). Recombinant factor VIIa (NovoSeven®) restores deficient coagulation: Experience from an ex vivo model. Seminars in Hematology. 38(4 Suppl 12). 10–14. 15 indexed citations
5.
Tàssies, Dolors, Gerard Espinosa, Francisco J. Muñoz, et al.. (2000). The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis & Rheumatism. 43(10). 2349–2358. 60 indexed citations
6.
Reverter, Joan Carles, Dolors Tàssies, S Maragall, et al.. (1995). [Hemorrhagic incidents during prolonged ambulatory treatment with acenocoumarol].. PubMed. 105(4). 127–30. 3 indexed citations
7.
Escolar, Ginés, Maribel Díaz‐Ricart, M Garrido, et al.. (1992). A variant of Glanzmann's thrombasthenia which fails to express a GPIIb–IIIa related epitope that is recognized by a specific monoclonal antibody (C17). British Journal of Haematology. 81(4). 545–551. 5 indexed citations
8.
Maragall, S, et al.. (1979). Inhibition of Willebrand factor in von Willebrand disease. Thrombosis Research. 14(2-3). 495–500. 7 indexed citations
9.
Ordinas, Antonio, S Maragall, R. Castillo, & Alan T. Nurden. (1978). A glycoprotein I defect in the platelets of three patients with severe cirrhosis of the liver. Thrombosis Research. 13(2). 297–302. 37 indexed citations
10.
Bosch, J., et al.. (1977). Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis.. Gut. 18(7). 556–560. 65 indexed citations
11.
Maragall, S, et al.. (1977). Inhibition of the Platelet Function by the Effect of Plasmin on Human Factor VIII. Thrombosis and Haemostasis.
12.
Castillo, R., et al.. (1977). Increased factor VIII complex and defective ristocetin-induced platelet aggregation in liver disease. Thrombosis Research. 11(6). 899–906. 24 indexed citations
13.
Maragall, S, et al.. (1976). Inhibition of Human Platelet Aggregation by the Proteolytic Effect of Streptokinase Role of the Human Factor-VIII-Related Protein. Pathophysiology of Haemostasis and Thrombosis. 5(5). 306–317. 2 indexed citations
14.
Maragall, S, et al.. (1975). Proceedings: Experimental modification of the platelet release reaction induced by collagen.. PubMed. 34(2). 574–574.
15.
16.
Bruguera, Miguel, S Maragall, Jordi Bosch, Joan Caballería, & J Rodés. (1971). HEPATITIS-ASSOCIATED ANTIGEN IN EPIDEMIC HEPATITIS. The Lancet. 297(7698). 549–549. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliane Bandinelli Breakdown of academic impact, for papers by I. A. G. Reilly Breakdown of academic impact, for papers by Nuria García‐Barberá Breakdown of academic impact, for papers by C Cordova Breakdown of academic impact, for papers by Caroline Moreau Breakdown of academic impact, for papers by J Clèdes Breakdown of academic impact, for papers by Virginia Pérez-Andreu Breakdown of academic impact, for papers by Sandro Parrotto Breakdown of academic impact, for papers by G. D. Qureshi
Rankless by CCL
2026